Tue, August 17, 2010
Mon, August 16, 2010
Sat, August 14, 2010
Fri, August 13, 2010
Thu, August 12, 2010
[ Thu, Aug 12th 2010 ] - Market Wire
30 p.m. EDT
Wed, August 11, 2010
Tue, August 10, 2010
Mon, August 9, 2010
Sun, August 8, 2010
Sat, August 7, 2010
Fri, August 6, 2010
Thu, August 5, 2010
[ Thu, Aug 05th 2010 ] - Market Wire
Mortgage Rates Continue to Drop
Wed, August 4, 2010
Tue, August 3, 2010
Mon, August 2, 2010
[ Mon, Aug 02nd 2010 ] - Market Wire
00 p.m. Pacific Time
Fri, July 30, 2010
Thu, July 29, 2010
Wed, July 28, 2010

Phase Forward Announces United States Department of Justice Clearance


//science-technology.news-articles.net/content/2 .. ited-states-department-of-justice-clearance.html
Published in Science and Technology on by Market Wire   Print publication without navigation


WALTHAM, Mass.--([ BUSINESS WIRE ])--Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced that the United States Department of Justice has closed its investigation of the proposed acquisition of Phase Forward by Oracle Corporation (the aMergera), and that the waiting period under the Hard-Scott-Rodino Antitrust Improvements Act of 1976 regarding the Merger has been terminated. Completion of the proposed merger remains subject to the satisfaction or waiver of the other closing conditions specified in the merger agreement.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forwarda™s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter& Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at [ www.phaseforward.com ].

Safe Harbor for Forward Looking Statements

Certain items in this press release may constitute forward-looking statements within the meaning of the asafe harbora provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involved certain risks and uncertainties that could cause actual results to differ materially from those indicated in such forward-looking statements, including, but not limited to, the ability to complete the merger in light of the various closing conditions; the impact of the announcement or the closing of the merger on Phase Forwarda™s relationships with its employees, existing customers or potential future customers; the ability of Oracle to successfully integrate Phase Forwarda™s operations and employees; the ability to realize anticipated synergies and costs savings of the proposed merger; and such other risks detailed in the Phase Forwarda™s Annual Report on Form10-K filed with the SEC on February26, 2010 and other reports filed with the SEC.


Publication Contributing Sources